TMBIM1
Protein lifeguard 3
Also known as: LFG3, LFG3_HUMAN, PP1201, RECS1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969X1
- Gene
- TMBIM1
- Ensembl
- ENSG00000135926
- Chromosome
- 2
- Canonical length
- 311 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables death receptor binding activity. Involved in negative regulation of Fas signaling pathway; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; and negative regulation of protein localization to plasma membrane. Located in Golgi membrane; endosome membrane; and lysosomal membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
311 residues, UniProt reviewed canonical sequence.
>Q969X1|TMBIM1
1 MSNPSAPPPY EDRNPLYPGP PPPGGYGQPS VLPGGYPAYP GYPQPGYGHP AGYPQPMPPT
61 HPMPMNYGPG HGYDGEERAV SDSFGPGEWD DRKVRHTFIR KVYSIISVQL LITVAIIAIF
121 TFVEPVSAFV RRNVAVYYVS YAVFVVTYLI LACCQGPRRR FPWNIILLTL FTFAMGFMTG
181 TISSMYQTKA VIIAMIITAV VSISVTIFCF QTKVDFTSCT GLFCVLGIVL LVTGIVTSIV
241 LYFQYVYWLH MLYAALGAIC FTLFLAYDTQ LVLGNRKHTI SPEDYITGAL QIYTDIIYIF
301 TFVLQLMGDR NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMBIM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 333 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 333 nTPM
- blood vessel: 288 nTPM
- pancreas: 237 nTPM
- adipose tissue: 216 nTPM
- vagina: 215 nTPM
- stomach: 206 nTPM
Single-cell type
- esophageal apical cells: 1,556 nCPM
- platelets: 634 nCPM
- esophageal suprabasal cells: 409 nCPM
- syncytiotrophoblasts: 369 nCPM
- pancreatic acinar cells: 351 nCPM
- enterocytes: 292 nCPM
Immune cell
- basophil: 355 nTPM
- eosinophil: 299 nTPM
- non-classical monocyte: 223 nTPM
- total PBMC: 190 nTPM
- intermediate monocyte: 173 nTPM
- neutrophil: 167 nTPM
Brain region
- medulla oblongata: 313 nTPM
- midbrain: 200 nTPM
- white matter: 198 nTPM
- spinal cord: 197 nTPM
- pons: 189 nTPM
- thalamus: 185 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TMBIM1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 77 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic signaling pathway
- negative regulation of catalytic activity
- negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- negative regulation of Fas signaling pathway
- negative regulation of neuron apoptotic process
- negative regulation of protein localization to plasma membrane
- positive regulation of blood vessel remodeling
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMBIM1 as an antibody target. Whether an autoantibody or antibody against TMBIM1 could matter depends on whether native TMBIM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMBIM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMBIM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...